Recent analysis of US regulatory data reveals that MDH, a popular Indian spice brand, has faced an average rejection rate of 14.5% for its US shipments since 2021 due to bacterial presence. Hong Kong recently suspended sales of MDH’s and another Indian company’s spice blends due to high levels of a cancer-causing pesticide. While both companies assert product safety, investigations are ongoing in the US, Australia, and India. MDH, over a century old, has faced previous rejections, primarily for salmonella contamination. Everest, another major Indian spice maker, has had fewer rejections, emphasizing product safety.